Join us on April 23rd for our 2025 Global Metals & Minerals Project Spending Outlook! RSVP Today!
Sales & Support: +1 800 762 3361
For more information call: +1 800 762 3361
GALWAY, IRELAND--January 22, 2024--Written by Martin Lynch, European News
Editor for Industrial Info (Galway, Ireland)--Buoyed by the runaway success of its diabetes and weight loss drugs Ozempic and Wegovy, Denmark's Novo Nordisk A/S (NYSE:NVO) (Bagsværd, Denmark) has plans to build a major manufacturing operation at its Grange Castle campus in Dublin, Ireland.
Within this article: Details new plant investment in Dublin to boost production of Ozempic and Wegovy, scale, timeline, related European investments
(All Fields Required)
For More Info!
